HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Zeynep Eroglu Selected Research
Zeynep Eroglu Research Topics
Disease
64
Melanoma (Melanoma, Malignant)
05/2024 - 10/2011
31
Neoplasms (Cancer)
05/2024 - 01/2013
11
Neoplasm Metastasis (Metastasis)
01/2023 - 01/2014
4
Squamous Cell Carcinoma (Epidermoid Carcinoma)
06/2023 - 01/2019
4
Brain Neoplasms (Brain Tumor)
01/2022 - 01/2019
3
Basal Cell Carcinoma (Rodent Ulcer)
10/2023 - 01/2021
3
Merkel Cell Carcinoma
01/2022 - 10/2019
2
Skin Neoplasms (Skin Cancer)
01/2024 - 01/2022
2
Exanthema (Rash)
09/2023 - 01/2021
2
Lung Neoplasms (Lung Cancer)
01/2022 - 01/2013
2
Fever (Fevers)
02/2020 - 01/2019
2
Uveal melanoma
01/2020 - 11/2016
2
Disease Progression
12/2015 - 02/2014
2
Breast Neoplasms (Breast Cancer)
02/2014 - 01/2013
1
Fatigue
05/2024
1
Acute Kidney Injury (Acute Renal Failure)
09/2023
1
Encephalitis (Encephalitis, Rasmussen)
10/2021
1
COVID-19
01/2021
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021
1
Pneumonia (Pneumonitis)
11/2019
1
Left Ventricular Dysfunction
01/2019
1
Colitis
01/2019
1
Hemorrhage
01/2017
1
Purpura
01/2017
1
Thrombocytopenia (Thrombopenia)
01/2017
1
Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/2017
1
Intracranial Hemorrhages (Intracranial Hemorrhage)
01/2017
1
Fibrosis (Cirrhosis)
01/2016
Drug/Important Bio-Agent (IBA)
20
Ipilimumab
IBA
01/2024 - 01/2016
14
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
09/2023 - 12/2015
12
Immune Checkpoint Inhibitors
IBA
01/2024 - 01/2017
11
Nivolumab
IBA
01/2024 - 11/2016
7
Antibodies
IBA
12/2022 - 11/2016
7
pembrolizumab
IBA
12/2022 - 11/2016
6
Vemurafenib
IBA
09/2023 - 12/2015
5
RNA (Ribonucleic Acid)
IBA
09/2023 - 01/2013
4
Biomarkers (Surrogate Marker)
IBA
01/2023 - 10/2019
4
encorafenib
IBA
10/2021 - 01/2018
3
Proteins (Proteins, Gene)
FDA Link
01/2023 - 01/2013
3
Interleukin-2 (IL2)
IBA
01/2021 - 11/2015
3
trametinib
IBA
01/2021 - 01/2018
3
dabrafenib
IBA
01/2021 - 01/2016
3
Steroids
IBA
11/2019 - 01/2017
3
Ligands
IBA
12/2018 - 11/2016
2
Prednisone (Sone)
FDA Link
Generic
01/2024 - 01/2019
2
cemiplimab
IBA
10/2023 - 01/2021
2
cobimetinib
IBA
09/2023 - 10/2021
2
B7-H1 Antigen
IBA
01/2023 - 01/2022
2
Drug Combinations
IBA
01/2022 - 01/2021
2
Death Domain Receptors
IBA
01/2022 - 11/2016
2
Adrenal Cortex Hormones (Corticosteroids)
IBA
10/2021 - 01/2017
2
ceritinib
IBA
01/2021 - 01/2018
2
Small Cytoplasmic RNA
IBA
01/2021 - 01/2021
2
Phosphotransferases (Kinase)
IBA
01/2021 - 01/2018
2
binimetinib
IBA
12/2020 - 01/2018
2
L-Lactate Dehydrogenase (Lactate Dehydrogenase)
IBA
07/2019 - 01/2018
1
prednylidene (Pred)
IBA
01/2024
1
Tacrolimus (Prograf)
FDA Link
Generic
01/2024
1
Heat-Shock Proteins (Heat-Shock Protein)
IBA
09/2023
1
Cetuximab (Erbitux)
FDA Link
06/2023
1
Circulating Tumor DNA
IBA
01/2023
1
Programmed Cell Death 1 Receptor
IBA
12/2022
1
Interferons
IBA
01/2021
1
Melanoma-Specific Antigens
IBA
01/2021
1
Immunosuppressive Agents (Immunosuppressants)
IBA
01/2021
1
ibrutinib
IBA
01/2021
1
Interferon alpha-2 (Roferon-A)
FDA Link
01/2020
1
Messenger RNA (mRNA)
IBA
10/2019
1
sapanisertib
IBA
01/2018
1
Mechanistic Target of Rapamycin Complex 1
IBA
01/2018
1
Lactate Dehydrogenase 5
IBA
01/2018
1
Inosine Triphosphate (ITP)
IBA
01/2017
1
Intravenous Immunoglobulins (IVIG)
FDA Link
01/2017
1
CTLA-4 Antigen
IBA
01/2017
1
Microphthalmia-Associated Transcription Factor
IBA
04/2016
1
Catenins
IBA
04/2016
1
Reactive Oxygen Species (Oxygen Radicals)
IBA
04/2016
1
Proto-Oncogene Proteins B-raf
IBA
01/2016
1
Creatinine
IBA
01/2016
1
Bilirubin
IBA
01/2016
1
Mitogen-Activated Protein Kinases
IBA
01/2016
1
peginterferon alfa-2b (Pegintron)
FDA Link
01/2016
1
Cytokines
IBA
11/2015
1
Cancer Vaccines
IBA
11/2015
1
Immunoglobulins (Immunoglobulin)
IBA
11/2015
1
tremelimumab
IBA
11/2015
1
Immunoglobulin G (IgG)
IBA
11/2015
Therapy/Procedure
56
Therapeutics
05/2024 - 10/2011
15
Immunotherapy
06/2023 - 11/2015
7
Drug Therapy (Chemotherapy)
01/2022 - 10/2011
3
Lymph Node Excision (Lymph Node Dissection)
01/2023 - 11/2021
2
Radiotherapy
01/2022 - 01/2019
2
Aftercare (After-Treatment)
01/2020 - 01/2017
2
Neoadjuvant Therapy
01/2020 - 10/2019
1
Long-Term Care
05/2024
1
Intralesional Injections
04/2024
1
Drug Tapering
09/2023
1
Adjuvant Radiotherapy
01/2023
1
Oncolytic Virotherapy
01/2020
1
Cell- and Tissue-Based Therapy (Cell Therapy)
01/2018